RebeccaArendMD
Obstetrics & Gynecology • Birmingham, ALGynecologic Oncology
Academic Appointment: Associate Professor - UAB Women & Infants Center
Dr. Arend is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-297-9411
Summary
- Dr. Rebecca Arend is an obstetrician/gynecologist in Birmingham, AL and is affiliated with UAB Hospital. She received her medical degree from Albert Einstein College of Medicine and has been in practice 9 years. She specializes in gynecologic oncology and is experienced in gynecologic oncology.
Education & Training
University of Alabama Medical CenterFellowship, Gynecologic Oncology, 2015
New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2008 - 2012
Albert Einstein College of MedicineClass of 2008
Certifications & Licensure
AL State Medical License 2012 - 2024
NY State Medical License 2011 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer Start of enrollment: 2017 Nov 15
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma Start of enrollment: 2018 Mar 05
- Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer Start of enrollment: 2023 May 01
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsObesity diminishes response to PD-1-based immunotherapies in renal cancer.Shannon K. Boi, Rachael M. Orlandella, Justin T. Gibson, William J. Turbitt, Gal Wald
Journal for Immunotherapy of Cancer. 2020-12-01 - 40 citationsMolecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C. Arend, Angelina I. Londono, Allison M. Montgomery, Haller J. Smith, Zachary C. Dobbin
Molecular Cancer Research. 2018-03-09 - 11 citationsTP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.Karley Whelan, Mairead Dillon, Kyle C Strickland, Bhavana Pothuri, Victoria Bae-Jump
Gynecologic Oncology. 2023-11-01
Press Mentions
Immunotherapy’s Role in Treating Endometrial Cancer Expected to GrowApril 12th, 2023- Two “Homerun” Trials Expected to Change Standard for Advanced, Recurrent Endometrial CancerMarch 28th, 2023
- The Drug Zejula Shows Important Long-Term, Progression-Free Survival Benefit for Patients with Advanced Ovarian CancerOctober 13th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
